BIO Protocol skyrocketed 24% in a day, yet the funding rate dipped to -0.07%. Are the shorts getting squeezed?
Today, I noticed something interesting about BIO Protocol's market. This modular execution layer protocol based on the Base chain surged 24% in just 24 hours, climbing from 0.032 to over 0.041, pushing its market cap close to $7 million.
But what's really catching attention is the funding rate. The latest 12-hour funding rate has dropped to -0.0727%, which means a lot of shorts are paying hefty funding fees to the longs. With the price rising, this is typically a short squeeze signal.
Let's take a look at the volume distribution: it started breaking out at 9 AM, and between 10 and 11 AM, the trading volume exceeded $280,000, more than 10 times the previous average. Subsequently, the price stabilized above 0.04, with buy orders continuously flooding in.
However, there are a few risk points to keep an eye on. The top 10 addresses hold 75% of the supply, which is quite concentrated. Out of 25,000 holders, only 218 are KYC verified, indicating that the community's maturity is still in question.
Bio Protocol itself is a legitimate DeFi project with a whitepaper, supporting multi-chain deployments on Base, Solana, and BSC. The "community recognized" tag shows it has garnered some attention.
Currently, the funding rate is extremely bearish, yet the price is rising; such divergence often doesn't last long. Once the shorts start to close their positions, it could accelerate upward. But high concentration means that whales could dump at any moment.
How long do you think this short squeeze can last?
Today, I noticed something interesting about BIO Protocol's market. This modular execution layer protocol based on the Base chain surged 24% in just 24 hours, climbing from 0.032 to over 0.041, pushing its market cap close to $7 million.
But what's really catching attention is the funding rate. The latest 12-hour funding rate has dropped to -0.0727%, which means a lot of shorts are paying hefty funding fees to the longs. With the price rising, this is typically a short squeeze signal.
Let's take a look at the volume distribution: it started breaking out at 9 AM, and between 10 and 11 AM, the trading volume exceeded $280,000, more than 10 times the previous average. Subsequently, the price stabilized above 0.04, with buy orders continuously flooding in.
However, there are a few risk points to keep an eye on. The top 10 addresses hold 75% of the supply, which is quite concentrated. Out of 25,000 holders, only 218 are KYC verified, indicating that the community's maturity is still in question.
Bio Protocol itself is a legitimate DeFi project with a whitepaper, supporting multi-chain deployments on Base, Solana, and BSC. The "community recognized" tag shows it has garnered some attention.
Currently, the funding rate is extremely bearish, yet the price is rising; such divergence often doesn't last long. Once the shorts start to close their positions, it could accelerate upward. But high concentration means that whales could dump at any moment.
How long do you think this short squeeze can last?